These findings were confirmed by studies demonstrating increased TGF-β mediated signalling in patients with Marfan syndrome and by identification of gain-of-function mutations within the TGFBR1 and TGBR2 genes in patients with Loyes-Dietz syndrome [16,17]. This evidence concerns the gene TGFBR1 and Marfan syndrome.